Company
Headquarters: Changsha, China
Employees: 2,627
CN¥4.96 Billion
CNY as of Jan. 1, 2025
US$679.3 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Hunan Fangsheng Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. It offers medicines in the form of tablets, capsules, and granules for cardiovascular and cerebrovascular, orthopedic, pediatric, gynecological, traumatology, and anti-infectives. The company was founded in 2002 and is based in Changsha, China.
Hunan Fangsheng Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603998 wb_incandescent